Company / EPS (Diluted)
Black Diamond Therapeutics, Inc. EPS (Diluted) History
FY2019-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$16.99
FY2020
5-year range
-$16.99 / -$4.42
FY2019-FY2020
Trend
-284.4%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-16.99 in FY2020.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, eps (diluted) decreased 284.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.60 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$16.99 | -284.4% |
| FY2019 | -$4.42 | - |
As of FY2020 · SEC Form 10-K · Last checked Jun 21, 2026